| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/01/2006 | CN1243732C Isolation of carotenoid crystals |
| 03/01/2006 | CN1243730C Cinnamoylaminoalkyl-substd. benzenesulfonamide derivs. |
| 03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
| 03/01/2006 | CN1243723C N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 03/01/2006 | CN1243721C Substituted amino compounds and their use as substances having analgesic effect |
| 03/01/2006 | CN1243566C Car sickness preventing beverage |
| 03/01/2006 | CN1243565C Traditional Chinese medicine pain-relieving bag |
| 03/01/2006 | CN1243558C Externally applied medicine for treating bone ulcer and its preparation method |
| 03/01/2006 | CN1243555C Medicine for treating neurasthenia and preparing method and use |
| 03/01/2006 | CN1243551C Carbohydrate formulation (prebiotic adjuvant) for enhancement of immune response |
| 03/01/2006 | CN1243550C Pharmaceutical compositions and uses for androst-5-ene-3beta, 17 beta-diol and use thereof |
| 03/01/2006 | CN1243549C Ursolic acid cyano acrylic ester nano particle freeze dried powder for ampoule agent and its preparation method |
| 03/01/2006 | CN1243548C Eye drops |
| 03/01/2006 | CN1243547C New formulation |
| 03/01/2006 | CN1243546C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 03/01/2006 | CN1243545C DNA-cleaving antitumor agents |
| 03/01/2006 | CN1243544C Taxusol composition and its preparing process |
| 03/01/2006 | CN1243543C Bioimplant formulation |
| 03/01/2006 | CN1243542C Composition comprising free amino acids |
| 03/01/2006 | CN1243541C 2-(alpha-hydroxypentyl) benzoate and its preparing process and usage |
| 03/01/2006 | CN1243540C Combination of active principles for treating senile dementia such as alzheimer dementia |
| 03/01/2006 | CN1243538C Ursolic acid bean phospholipid nano particle freeze drying powder for ampoule agent and its preparation method |
| 03/01/2006 | CN1243537C Use of composition containing at least one oxidative sensitive hydrophilic active ingredient through at least one maleic anhydride copolymer stabilization at cosmetic and /or skin |
| 02/28/2006 | USRE38994 Pyropheophorbides conjugates and their use in photodynamic therapy |
| 02/28/2006 | US7005553 such as 2-nitrophenol by reacting 3-hydroxy-4-methoxybenzophenone with alkyl nitrate in presence of regioselective acid catalyst (sulfuric acid) |
| 02/28/2006 | US7005546 Acetamidobenzamide compounds for neurodegenerative disorders |
| 02/28/2006 | US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
| 02/28/2006 | US7005531 Method of making iron(III)gluconate complex |
| 02/28/2006 | US7005526 Thioether derivatives |
| 02/28/2006 | US7005524 Piperidine compounds such as 1-(2-phenylethyl)-3-(1-(phenylamino)ethyl)piperidine useful as or intermediates to compounds that treat conditions and diseases that afflict mammals, including addiction and pain |
| 02/28/2006 | US7005523 Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines |
| 02/28/2006 | US7005519 Formed in a one pot process by reacting a benzyl nitrile compound in a base in the presence of a halogenating agent; e.g. octa(ortho-trifluormethylphenyl)tetraazaporphyrin from o-trifluoromethylbenzyl cyanide and iodine; solvent solubility |
| 02/28/2006 | US7005516 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005508 Nitroderivatives of polysaccharides |
| 02/28/2006 | US7005453 Plant extracts comprising tetrahydroiso alpha acid or hexahydro beta acid at concentrations effective againsts staphylococcus aureus but not lactobacillus; preferential; disposable products |
| 02/28/2006 | US7005452 administering enantiomorphs comprising (Z(+-)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide hydrochloride), as serotonin and adrenergic uptake inhibitors, with side effect reduction; antidepressants |
| 02/28/2006 | US7005450 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2006 | US7005449 Tolterodine salts |
| 02/28/2006 | US7005448 Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma |
| 02/28/2006 | US7005447 Increases the level of enterolactone or another metabolite of hydroxymatairesinol in a person's serum |
| 02/28/2006 | US7005446 selected from beta-naphthoflavone, 3-methylcholanthrene, and tert-butylhydroquinone; Activator protein-1 (AP-1) |
| 02/28/2006 | US7005445 Protein kinase and phosphatase inhibitors and methods for designing them |
| 02/28/2006 | US7005444 3-(heteroarylamino)methylene-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/28/2006 | US7005443 5-Hydroxy indazole derivatives for treating glaucoma |
| 02/28/2006 | US7005442 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 02/28/2006 | US7005441 Fluroescence analysis; controlling transcription factors; bactericides, viricides, anticancer agents, fungicides, antiprotozoa agents |
| 02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
| 02/28/2006 | US7005439 Compounds |
| 02/28/2006 | US7005438 Pharmaceutically active isoindoline derivatives |
| 02/28/2006 | US7005437 Substituted aryl and heteroaryl derivatives, the preparation thereof and the use therof as pharmaceutical compositions |
| 02/28/2006 | US7005436 Heterocyclo inhibitors of potassium channel function |
| 02/28/2006 | US7005435 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors |
| 02/28/2006 | US7005434 Compounds and uses thereof |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/28/2006 | US7005432 Central nervous system disorder; antidepressants; analgesics |
| 02/28/2006 | US7005431 Imidazo-triazine derivatives as ligands for gaba receptors |
| 02/28/2006 | US7005430 Such as (R)-2-cyclopentyl-7,8-dihydro-8-(4-picolyl)-4-(n-propyl)-1H-imidazo(2,1 -i)purin-5(4H)-one d-tartaric acid, which has glucose concentration-dependent insulin secretion promoting action/hypoglycemic activity; antidiabetic agents |
| 02/28/2006 | US7005429 Administering antineoplastic amount of dihydroequilin or metabolic conjugate orally, parenterally, transdermally, topically, rectally, intravaginally, intranasally, or intrabronchially |
| 02/28/2006 | US7005428 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/28/2006 | US7005427 Containing silicon dioxide particles whose surface is positively charged; used for producing a film in a solution casting method; reduce the aggregation of solid materials during filtration prior to casting |
| 02/28/2006 | US7005426 Complexes enter into cells via the pathway of the folic acid receptor on the cell membranes and then kill tumor cells in vivo and suppress the growth of tumor tissues without injuring normal cells; antitumor, -carcinogenic agents |
| 02/28/2006 | US7005425 Administering a minimal dose of an Al adenosine receptor agonist in conjunction with a minimal dose of a beta blocker, calcium channel blocker, or cardiac glycoside |
| 02/28/2006 | US7005424 Admininstering mixtures of anticarcinogenic agents and early genes for prophylaxis of cancer, tumors or metastasis; gene expression inhibitors |
| 02/28/2006 | US7005423 identifying DNA responsible for conferring a phenotype of a Caenorhabditis elegans (C. elegans) cell or organism |
| 02/28/2006 | US7005422 Derivatives of monosaccharides as cell adhesion inhibitors |
| 02/28/2006 | US7005421 Doxorubicin hydrochloride acidic solution which has not been reconstituted from lyophilizate |
| 02/28/2006 | US7005416 Synergistic; treating grampositive and gramnegative bacterial infections, kits |
| 02/28/2006 | US7005415 Wherein the DNA synthesis promoting activity of the heparin-binding protein is increased by the covalently bonded sugar chain which can be heparan sulfate; improved in vivo stabilities such as acid resistance and alkali resistance |
| 02/28/2006 | US7005408 Anhydrous warming, non- toxic and nonirritating lubricating compositions containing polyhydric alcohols and an insulating agent. The invention also relates to methods of using such compositions for lubrication, administration of active |
| 02/28/2006 | US7005297 Use of neuroactive compounds |
| 02/28/2006 | US7005280 Method of producing lipids by growing microorganisms of the order thraustochytriales |
| 02/28/2006 | US7005269 ERAAP modulators regulate immune responses |
| 02/28/2006 | US7005252 Serum free cultivation of primate embryonic stem cells |
| 02/28/2006 | US7005144 Antler composition and its manufacturing process |
| 02/28/2006 | US7005143 Gel materials, medical articles, and methods |
| 02/28/2006 | US7005141 Modified amino acids and derivatives can form non-covalent mixtures with active biological agents and in an alternate embodiment can releasably carry active agents. Modified amino acids can also form drug containing microspheres. |
| 02/28/2006 | US7005138 Intravaginal or rectal delivery of selected serotonin reuptake inhibitors (ssris); antidepressants, analgesics, treating psychological disorders, pre-menstrual dysphoric disorder and obsessive compulsive disorders |
| 02/28/2006 | US7005125 Maleic compound modified polyolefin |
| 02/28/2006 | US7005124 High drug efficiency, high drug carrying capacity, good water solubility, good stability on storage, reduced toxicity, and improved anti-tumor activity in vivo |
| 02/28/2006 | US7005122 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route |
| 02/28/2006 | US7005121 Arerosol; heating drug, vaporization, cooling |
| 02/28/2006 | US7004976 Biopolymers modified with superoxide dismutase mimics |
| 02/28/2006 | US7004945 Devices and methods for the restoration of a spinal disc |
| 02/28/2006 | US7004834 System and method for facilitating play of a game with user-selected elements |
| 02/28/2006 | CA2382426C Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| 02/28/2006 | CA2373117C 13-methyl-erythromycin derivatives |
| 02/28/2006 | CA2347469C Esters of (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 100,907 |
| 02/28/2006 | CA2332535C Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 02/28/2006 | CA2331877C Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/28/2006 | CA2251916C Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementaton and an energy supplement containing such an additive |
| 02/28/2006 | CA2204204C Carbohydrate derivatives |
| 02/28/2006 | CA2180444C Water soluble onium salt of taxo-diterpenoid |
| 02/28/2006 | CA2173116C Ring-expanded nucleosides and nucleotides |
| 02/28/2006 | CA2170537C Enteric coated oral compositions containing bisphosphonic acid derivatives |
| 02/28/2006 | CA2144770C Brain cell protective agent |
| 02/28/2006 | CA2123946C Cyclodextrin inclusion product of paclitaxel, process for producing the same, and its use |
| 02/24/2006 | CA2533320A1 2, 4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 02/23/2006 | WO2006021008A2 Ionophores as cancer chemotherapeutic agents |
| 02/23/2006 | WO2006021002A2 Compounds useful for inhibiting chk1 |
| 02/23/2006 | WO2006021001A2 Amphiphilic polynorbornene derivatives and methods of using the same |